The Need for “Compassionate Provider Profiling” Refining Risk Assessment for Percutaneous Coronary Intervention⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology. by Peterson, Eric D.
Journal of the American College of Cardiology Vol. 57, No. 8, 2011
© 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.10.022EDITORIAL COMMENT
The Need for “Compassionate
Provider Profiling”
Refining Risk Assessment for
Percutaneous Coronary Intervention*
Eric D. Peterson, MD, MPH
Durham, North Carolina
In today’s “transparent” society, the public is increasingly
demanding more information on the quality and outcomes
of medical care (1,2). Most would agree that patients need
more data regarding their health care providers’ results, yet
the devil is always in the details. For outcome comparisons
to be fair and valid, they first need to be adjusted for
underlying patient risks (3). For percutaneous coronary
intervention (PCI), outcome metrics (e.g., acute mortality)
must account for multiple potential confounding factors
including patient demographics, disease severity, comorbid
illness, and, most importantly, procedural acuity.
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The science of outcomes risk assessment needs to con-
tinually evolve to keep up with an ever-changing medical
field and care environment (4). Historically, hospital com-
parisons were based on claims (or billing) data. Although
claims data were ubiquitous, they often proved inaccurate
and lacked many critical factors needed for proper risk
adjustment (5). During the past 2 decades, multicenter
clinical registries evolved and spread, helping to accelerate
our understanding of PCI procedural risk. In 1998, a group
of 8 pioneer PCI databases were used to identify key
variables associated with PCI risk (6). Since then, the
majority of U.S. PCI hospitals have consolidated data
submission into a single National Cardiovascular Data
Registry (NCDR). The NCDR expanded the number of
data elements collected, standardized their definitions, and
improved their completeness and accuracy (7). The resulting
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Squibb, Merck & Co., Tethysbio, and AstraZeneca.larger, higher quality database has facilitated the develop-
ment of more precise PCI risk models. The current NCDR
risk model adjusts for 21 independent factors and accu-
rately identifies those who will survive a PCI hospitalization
and those who will die in 93% of cases (c-index 0.93) (8).
In this issue of the Journal, Resnic et al. (9) assess whether
PCI risk algorithms could be further improved by refining the
variables used to summarize procedural acuity. Specifically, a
previous case review had demonstrated that most PCI deaths
occurred among patients entering the catheterization lab in
extremis (10). Although the NCDR data capture many indi-
cators of disease acuity (e.g., ST-segment elevation myocardial
infarction, heart failure, shock), some of these life-threatening
factors were missed. To address this gap, Resnic et al. (9)
studied the incremental impact of 3 novel risk data elements on
predicting PCI mortality: 1) cardiopulmonary resuscitation; 2)
patients in a coma; or 3) those with a ventricular assist device
or extracorporeal bypass device. These 3 factors were combined
into a single composite term entitled compassionate use (CU)
PCI. Resnic et al. (9) found that while PCI was rarely
performed for CU indications (0.03% of all PCI cases), these
CU cases did indeed face very high mortality risks, with
in-hospital mortality rates approaching 70%. They also found
that the CU indicator added independent prognostic informa-
tion beyond traditional clinical risk factors within Massachu-
setts’ state PCI database.
Measuring how these data affect patient risk stratification,
hospital performance assessment, and resource requirements
deserves further discussion. From a statistical standpoint,
the gains in risk prediction provided by the inclusion of CU
in the PCI risk model were modest. Overall model discrim-
ination (c-index) changed little (0.03), and 10% of pa-
tients were reclassified correctly to a higher (or lower) risk
group when CU was added (9).
Beyond patient-level risk prediction, one also needs to
consider how inclusion of the CU variable affects hospital-level
risk adjustment. With regards to performance assessment,
Resnic et al. (9) found individual hospital risk-adjusted mor-
tality rates were fairly static before and after adding the CU
indicator. In fact, in its first year of implementation, consider-
ation of CU had no effect on the classification of centers rated
as superior or inferior “outliers.” These findings were not
surprising because centers (on average) treated 3 CU cases
per year (9). Thus, while the risk models were incrementally
improved with inclusion of CU, these changes had limited
measurable impact on aggregated provider-level conclusions.
Additionally, one should consider the costs associated
with CU data implementation. Human resource costs in-
clude the need to educate sites regarding the definition of
CU, the personal time required for CU data collection, and
the subsequent central adjudication effort needed to validate
each reported CU case. For example, Resnic et al. (9) found
that in Massachusetts, despite state-wide training, up to
one-third of investigator-reported CU procedures were later
reversed after external audit. This stringent audit system
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February 22, 2011:912–3 Compassionate Provider Profilingused in the state further contributed to delays in release of
the outcomes information to the public. As a result, the
Massachusetts PCI mortality model reports were released
2 years after the last procedures were performed (11).
Despite these potential statistical and operational challenges,
the work of Resnic et al. (9) points out an extremely important
consequence of provider profiling programs; namely, how
provider perceptions of the PCI risk adjustment process itself
can affect their subsequent clinical actions. Faced with fears of
appearing on the front page of their local newspapers, inter-
ventionalists in Massachusetts may have thought twice before
attempting PCI on very high-risk patients (12). In fact, Resnic
et al. (9) found empirical support for this hypothesis. In the
rst 3 years after Massachusetts’ decision to publicly report
CI mortality, the use of coronary revascularization procedures
n shock patients decreased by 50%. However, after the
assachusetts Board began adjusting for CU factors, this
rend reversed, and interventionalists reverted to their pre-
rofiling procedure levels. Although such trends will need
ngoing evaluation, these initial findings are provocative indi-
ators of the influence of profiling methodology on provider
ase selection.
Can the Massachusetts CU experience be generalized to the
CDR PCI database? Perhaps. Currently, the NCDR re-
ains a voluntary registry whose goal is to provide clinicians
ith confidential feedback on their comparative care and
utcomes. In an era without the pressures of public reporting,
ospitals have limited incentive to up-code or “game” their
eported PCI risk data. Looking toward the future, however,
he world may be radically different. Beginning last fall, the
ociety of Thoracic Surgeons has agreed to publicly release
ospitals’ bypass surgery outcomes and care quality information
oConsumer Reports (13). This decision will put pressure on the
NCDR and other clinical registries to also release their data to
the public. Although such increased transparency is welcomed
by policy leaders who have advocated for these types of changes
(1,2), it will also likely (at least temporarily) increase the anxiety
of practicing clinicians. Thus, if and when professional society
registries are also used as public report cards, then the require-
ments for data accuracy and verification will be just as high as
those currently faced by Massachusetts.
Therefore, the study by Resnic et al. (9) has helped our
profession prepare in multiple ways for this near-term future.
First, Resnic et al. (9) have identified a rare but important set
of high-risk factors not previously collected in national regis-
tries. Second, the investigators have shown that these data
variables were potentially feasible to collect, providing that an
external validation is in place to ensure accuracy. Third, and
perhaps most important, they demonstrated that the extra data
collection and validation may be considered worthwhile, given
the positive impact of this process on provider behaviors.
Many have and will debate the relative merits and unin-
tended consequences of releasing outcomes data to the public
(14). Nevertheless, if such provider profiling is to be imple-
mented, I strongly believe that this profiling must be used
compassionately, in a manner that demonstrates concern foraccuracy and fairness to the physicians affected by its critique.
As a practicing coronary care unit physician, I rely on the skills
and judgment of my interventionalist partners. When I call on
my colleagues to consider taking an extremely sick patient to
the laboratory, I do not want them worrying about how a case
may adversely affect their outcomes score card; rather, I want
them to compassionately consider what can be done to save the
patient’s life.
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